Drug maker Abbott India today reported a net profit of Rs 14.07 crore for the quarter ended on May 31, 2010, a decline of 19.9 per cent compared to the similar period last year when it had reported a net profit of Rs 17.58 crore.
Abbott said in a statement today that during the quarter under consideration, net sales rose to Rs 224 crore, a growth of 15 per cent compared to Rs 193.82 crore in the same quarter last year.
The company follows a December-November fiscal year.
The Abott shares closed up 4.62 per cent at 1,160.75 on the Bombay Stock Exchange today on a day when the benchmark Sensex shed over 240 points.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app